Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

1.1K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

102
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
102
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

8.2K
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
8.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Building Intelligent ECG.

IEEE pulse·2026
Same authorSame journal

Benefits for Early Diagnosis, Treatment, and Research.

IEEE pulse·2026
Same author

Suite of Ingestible Devices Opens Window to the Gut Nervous System, Microbiome.

IEEE pulse·2026
Same author

Urine-Based Spectroscopy/AI Platform for Early Detection of Multiple Cancers.

IEEE pulse·2026
Same author

From Promise to Practice: Building the Open Infrastructure for Health Wearables.

IEEE pulse·2026
Same author

Beyond the Mask: Nerve Stimulation and Other Breakthroughs for Sleep Apnea.

IEEE pulse·2025

相关实验视频

Updated: Mar 8, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

5.2K

结果在一周到一个月内得到.

Leslie Mertz

    IEEE pulse
    |March 6, 2026
    PubMed
    概括

    研究人员在芯片上开发了微瘤,以快速测试癌症治疗方法. 这种创新方法还可以预测癌症转移,加速治疗的发展.

    科学领域:

    • 在瘤学瘤学.
    • 生物技术是生物技术.
    • 医学诊断 医学诊断 医学诊断

    背景情况:

    • 传统的癌症治疗测试是耗时的,并且可能是无效的.
    • 预测癌症转移仍然是一个重大的临床挑战.
    • 患者衍生模型对于个性化医学至关重要.

    研究的目的:

    • 开发一个快速可靠的平台,用于测试癌症疗法.
    • 创建一个模型,可以预测瘤的转移潜力.
    • 推进个性化的癌症治疗策略.

    主要方法:

    • 在微流体芯片上培养患者衍生的微瘤.
    • 使用芯片进行高通量药物选.
    • 分析微瘤的行为,以评估转移潜力.

    主要成果:

    • 治疗测试显著加快,在几天内完成,而不是几周或几个月.
    • 微瘤芯片在识别可能扩散的癌症方面表现出潜力.
    • 成功应用患者衍生模型进行个性化治疗评估.

    结论:

    • 芯片上的微瘤为癌症研究提供了更快,更具预测性的模型.

    更多相关视频

    Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU
    11:46

    Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU

    Published on: August 22, 2019

    11.7K
    Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly
    09:51

    Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly

    Published on: April 25, 2016

    8.1K

    相关实验视频

    Last Updated: Mar 8, 2026

    Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
    08:05

    Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

    Published on: December 9, 2022

    5.2K
    Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU
    11:46

    Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU

    Published on: August 22, 2019

    11.7K
    Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly
    09:51

    Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly

    Published on: April 25, 2016

    8.1K
  • 这项技术有可能彻底改变个性化癌症治疗.
  • 该平台可以通过实现更快,更有效的治疗选择来改善患者的治疗结果.